Multisorbent plasma perfusion in fulminant hepatic failure: effects of duration and frequency of treatment in rats with grade III hepatic coma

C.J. Ryan, T. Anilkumar, A.J.A. Ben-Hamida, S.E. Khorsandi, C.D. Pusey, J.D.S. Gaylor, J.M. Courtney, M. Aslam

    Research output: Contribution to journalArticle

    10 Citations (Scopus)

    Abstract

    Using the model of galactosamine-induced fulminant hepatic failure in the rat, the effects of multisorbent plasma perfusion over Asahi uncoated spherical charcoal, Plasorba (BR-350) resin, and an endotoxin removing adsorbent (polymyxin B-sepharose) were determined in Grade III hepatic coma animals by studying survival as influenced by timing, duration, and frequency of treatment. The effects of treatment on liver cell proliferation and endotoxin removal also were examined. The results demonstrate that duration and frequency of treatment are major contributing factors in the successful application of nonbiological membrane-based multisorbent liver support systems. Examination of the regenerative activity in the liver indicates an enhanced proliferative response following multisorbent plasma perfusion compared with untreated fulminant hepatic failure (FHF) paired controls. Utilizing an endotoxin removal adsorbent alone, a marked reduction in systemic levels of endotoxin in FHF was demonstrated compared with nonperfused FHF paired controls. Despite current emphasis on bioartificial liver support systems, plasma purification by multisorbent systems offers a simple method for the removal of circulating toxic metabolites in general together with specific toxin removal.
    Original languageEnglish
    Pages (from-to)109-118
    Number of pages9
    JournalArtificial Organs
    Volume25
    Issue number2
    DOIs
    Publication statusPublished - 2001

    Fingerprint

    Hepatic Encephalopathy
    Acute Liver Failure
    Endotoxins
    Liver
    Rats
    Perfusion
    Plasmas
    Adsorbents
    Galactosamine
    Artificial Liver
    Charcoal
    Poisons
    Cell proliferation
    Metabolites
    Purification
    Animals
    Resins
    Cell Proliferation
    Membranes

    Keywords

    • artificial organs
    • liver
    • bioengineering
    • plasma

    Cite this

    Ryan, C. J., Anilkumar, T., Ben-Hamida, A. J. A., Khorsandi, S. E., Pusey, C. D., Gaylor, J. D. S., ... Aslam, M. (2001). Multisorbent plasma perfusion in fulminant hepatic failure: effects of duration and frequency of treatment in rats with grade III hepatic coma. Artificial Organs, 25(2), 109-118. https://doi.org/10.1046/j.1525-1594.2001.025002109.x
    Ryan, C.J. ; Anilkumar, T. ; Ben-Hamida, A.J.A. ; Khorsandi, S.E. ; Pusey, C.D. ; Gaylor, J.D.S. ; Courtney, J.M. ; Aslam, M. / Multisorbent plasma perfusion in fulminant hepatic failure: effects of duration and frequency of treatment in rats with grade III hepatic coma. In: Artificial Organs. 2001 ; Vol. 25, No. 2. pp. 109-118.
    @article{b239ec36f76a45539660b42c42f31e71,
    title = "Multisorbent plasma perfusion in fulminant hepatic failure: effects of duration and frequency of treatment in rats with grade III hepatic coma",
    abstract = "Using the model of galactosamine-induced fulminant hepatic failure in the rat, the effects of multisorbent plasma perfusion over Asahi uncoated spherical charcoal, Plasorba (BR-350) resin, and an endotoxin removing adsorbent (polymyxin B-sepharose) were determined in Grade III hepatic coma animals by studying survival as influenced by timing, duration, and frequency of treatment. The effects of treatment on liver cell proliferation and endotoxin removal also were examined. The results demonstrate that duration and frequency of treatment are major contributing factors in the successful application of nonbiological membrane-based multisorbent liver support systems. Examination of the regenerative activity in the liver indicates an enhanced proliferative response following multisorbent plasma perfusion compared with untreated fulminant hepatic failure (FHF) paired controls. Utilizing an endotoxin removal adsorbent alone, a marked reduction in systemic levels of endotoxin in FHF was demonstrated compared with nonperfused FHF paired controls. Despite current emphasis on bioartificial liver support systems, plasma purification by multisorbent systems offers a simple method for the removal of circulating toxic metabolites in general together with specific toxin removal.",
    keywords = "artificial organs, liver, bioengineering, plasma",
    author = "C.J. Ryan and T. Anilkumar and A.J.A. Ben-Hamida and S.E. Khorsandi and C.D. Pusey and J.D.S. Gaylor and J.M. Courtney and M. Aslam",
    year = "2001",
    doi = "10.1046/j.1525-1594.2001.025002109.x",
    language = "English",
    volume = "25",
    pages = "109--118",
    journal = "Artificial Organs",
    issn = "0160-564X",
    number = "2",

    }

    Multisorbent plasma perfusion in fulminant hepatic failure: effects of duration and frequency of treatment in rats with grade III hepatic coma. / Ryan, C.J.; Anilkumar, T.; Ben-Hamida, A.J.A.; Khorsandi, S.E.; Pusey, C.D.; Gaylor, J.D.S.; Courtney, J.M.; Aslam, M.

    In: Artificial Organs, Vol. 25, No. 2, 2001, p. 109-118.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Multisorbent plasma perfusion in fulminant hepatic failure: effects of duration and frequency of treatment in rats with grade III hepatic coma

    AU - Ryan, C.J.

    AU - Anilkumar, T.

    AU - Ben-Hamida, A.J.A.

    AU - Khorsandi, S.E.

    AU - Pusey, C.D.

    AU - Gaylor, J.D.S.

    AU - Courtney, J.M.

    AU - Aslam, M.

    PY - 2001

    Y1 - 2001

    N2 - Using the model of galactosamine-induced fulminant hepatic failure in the rat, the effects of multisorbent plasma perfusion over Asahi uncoated spherical charcoal, Plasorba (BR-350) resin, and an endotoxin removing adsorbent (polymyxin B-sepharose) were determined in Grade III hepatic coma animals by studying survival as influenced by timing, duration, and frequency of treatment. The effects of treatment on liver cell proliferation and endotoxin removal also were examined. The results demonstrate that duration and frequency of treatment are major contributing factors in the successful application of nonbiological membrane-based multisorbent liver support systems. Examination of the regenerative activity in the liver indicates an enhanced proliferative response following multisorbent plasma perfusion compared with untreated fulminant hepatic failure (FHF) paired controls. Utilizing an endotoxin removal adsorbent alone, a marked reduction in systemic levels of endotoxin in FHF was demonstrated compared with nonperfused FHF paired controls. Despite current emphasis on bioartificial liver support systems, plasma purification by multisorbent systems offers a simple method for the removal of circulating toxic metabolites in general together with specific toxin removal.

    AB - Using the model of galactosamine-induced fulminant hepatic failure in the rat, the effects of multisorbent plasma perfusion over Asahi uncoated spherical charcoal, Plasorba (BR-350) resin, and an endotoxin removing adsorbent (polymyxin B-sepharose) were determined in Grade III hepatic coma animals by studying survival as influenced by timing, duration, and frequency of treatment. The effects of treatment on liver cell proliferation and endotoxin removal also were examined. The results demonstrate that duration and frequency of treatment are major contributing factors in the successful application of nonbiological membrane-based multisorbent liver support systems. Examination of the regenerative activity in the liver indicates an enhanced proliferative response following multisorbent plasma perfusion compared with untreated fulminant hepatic failure (FHF) paired controls. Utilizing an endotoxin removal adsorbent alone, a marked reduction in systemic levels of endotoxin in FHF was demonstrated compared with nonperfused FHF paired controls. Despite current emphasis on bioartificial liver support systems, plasma purification by multisorbent systems offers a simple method for the removal of circulating toxic metabolites in general together with specific toxin removal.

    KW - artificial organs

    KW - liver

    KW - bioengineering

    KW - plasma

    UR - http://dx.doi.org/10.1046/j.1525-1594.2001.025002109.x

    U2 - 10.1046/j.1525-1594.2001.025002109.x

    DO - 10.1046/j.1525-1594.2001.025002109.x

    M3 - Article

    VL - 25

    SP - 109

    EP - 118

    JO - Artificial Organs

    JF - Artificial Organs

    SN - 0160-564X

    IS - 2

    ER -